BiotechTube
GenEvolution

GenEvolution

Paris, France· Est.
genevolution.fr
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

GenEvolution is an independent, Paris-based CRO offering specialized, regulatory-grade in vitro toxicology and genotoxicity testing services. Founded by industry veterans from Sanofi and Covance, it operates from a state-of-the-art BSL2+ laboratory and holds key certifications from ANSM and COFRAC. The company serves a broad range of industries including pharma, cosmetics, and agro-science with a focus on innovative testing methods like FISH cytogenetics and miniaturized bacterial mutagenicity assays. Its business model is purely service-based, positioning it as a specialized partner for safety assessment in product development.

Genetics & GenomicsSynthetic Biology

Technology Platform

Suite of in vitro toxicology tests using human cell and reconstructed tissue models combined with advanced analytical technologies. Specialized in genotoxicity assays (Ames, micronucleus, FISH cytogenetics), phototoxicity, and non-genotoxic carcinogenicity screening. Operates in a GLP/ISO 17025 compliant BSL2+ lab.

Opportunities

The global shift away from animal testing, especially in cosmetics and chemicals, creates strong demand for advanced in vitro models.
Increasing regulatory complexity and the need for specialized genotoxicity expertise in pharmaceutical and agro-science R&D provide a steady stream of high-value projects.
Expansion into adjacent service areas like consulting and chemical analysis offers avenues for revenue growth.

Risk Factors

Faces intense competition from large, global CROs and commoditization of standard tests.
Reliance on maintaining stringent GLP and ISO certifications, where a single audit failure could damage reputation.
Market vulnerability to R&D spending cycles in its core client industries, such as pharmaceuticals and chemicals.

Competitive Landscape

GenEvolution competes in the fragmented CRO market for toxicology services. It differentiates itself as a specialized, mid-sized player with deep expertise in genotoxicity and a focus on innovative human-cell-based methods, competing against large full-service CROs (e.g., Charles River, LabCorp/Covance) and smaller niche labs. Its French regulatory certifications (ANSM, COFRAC) provide a competitive advantage in the European market.

More companies in Diagnostics & Precision Medicine →More companies in France →